Dr Mohamed Bouattour

Specialty

Onco-hepatology (hepatocellular carcinoma, cholangiocarcinoma, rare liver cancers)

Hospital

Hôpital Beaujon (Clichy)

Latest articles

• The "A-B-C" classification reveals outcome trajectories in patients with hepatocellular carcinoma under atezolizumab/bevacizumab. (Nov 25, 2025)
• Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma. (Nov 20, 2025)
• Palliative Care Referral Practices and Impact on Survival of Patients Diagnosed With Advanced Hepatocellular Carcinoma. (Nov 1, 2025)
• Correction: ESR Bridges: imaging and treatment of uncommon liver tumours-a multidisciplinary view. (Oct 17, 2025)
• PSMA immunohistochemistry as a diagnostic biomarker of hepatocellular carcinoma. (Jul 31, 2025)